Article
Cytokine genetic variations and fatigue among patients with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 May 2013
Bower Julienne E, Ganz Patricia A, Irwin Michael R, Castellon Steven, Arevalo Jesusa, Cole Steven W
Abstract excerpt
PURPOSE: Fatigue is a common adverse effect of cancer treatment and may persist for years after treatment completion. However, risk factors for post-treatment fatigue have not been determined. On the basis of studies suggesting an inflammatory basis for fatigue, this study tested the hypothesis that expression-regulating polymorphisms in proinflammatory cytokine genes would predict post-treatment fatigue in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
